Hartwig Klinker Selected Research

Hartwig Klinker Research Topics

Disease

26	Infections 01/2022 - 04/2006
18	Chronic Hepatitis C 01/2022 - 09/2008
15	Hepatitis C 01/2022 - 03/2012
10	Fibrosis (Cirrhosis) 07/2022 - 09/2008
6	Liver Diseases (Liver Disease) 01/2022 - 03/2017
6	Disease Progression 01/2020 - 01/2012
4	HIV Infections (HIV Infection) 07/2022 - 05/2004
4	Neoplasms (Cancer) 03/2022 - 01/2012
4	Liver Cirrhosis (Hepatic Cirrhosis) 01/2020 - 09/2008
4	Viremia 03/2013 - 04/2006
3	COVID-19 01/2022 - 01/2020
3	Hepatitis B 01/2020 - 01/2014
2	Chronic Renal Insufficiency 01/2022 - 11/2019
2	Virus Diseases (Viral Diseases) 01/2021 - 01/2019
2	Chronic Hepatitis B 01/2020 - 01/2020
2	Acquired Immunodeficiency Syndrome (AIDS) 11/2019 - 01/2016
2	Encephalitis (Encephalitis, Rasmussen) 11/2019 - 05/2004
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2014 - 01/2013
2	Inflammation (Inflammations) 01/2014 - 01/2012
1	Fatigue 01/2022
1	Nervous System Diseases (Neurological Disorders) 01/2022
1	Neurologic Manifestations (Neurological Manifestations) 01/2022
1	Headache (Headaches) 01/2022
1	Arthralgia (Joint Pain) 01/2022
1	Graft vs Host Disease (Graft-Versus-Host Disease) 12/2021
1	Bronchiolitis Obliterans Syndrome 12/2021
1	Primary Myelofibrosis (Myelosclerosis) 12/2021
1	Chronic Kidney Failure (Chronic Renal Failure) 11/2021
1	Weight Gain 10/2021
1	Kidney Diseases (Kidney Disease) 02/2021
1	Cytomegalovirus Infections (Inclusion Disease) 11/2020
1	Fever (Fevers) 01/2020
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2020
1	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia) 11/2019
1	Immune Reconstitution Inflammatory Syndrome 11/2019
1	Toxoplasmosis 11/2019
1	Critical Illness (Critically Ill) 11/2018
1	Neutropenia 06/2017
1	Invasive Fungal Infections 06/2017

Drug/Important Bio-Agent (IBA)

18	Antiviral Agents (Antivirals)IBA 01/2022 - 08/2009
8	Pharmaceutical PreparationsIBA 12/2021 - 05/2004
7	InterferonsIBA 10/2021 - 11/2011
6	Ribavirin (Virazole)FDA LinkGeneric 03/2017 - 04/2006
6	RNA (Ribonucleic Acid)IBA 01/2014 - 04/2006
4	NucleosidesIBA 01/2020 - 03/2012
4	SofosbuvirIBA 11/2019 - 01/2014
4	Protease Inhibitors (Protease Inhibitor)IBA 08/2013 - 05/2004
3	Alanine Transaminase (SGPT)IBA 01/2022 - 12/2011
3	elbasvirIBA 01/2022 - 07/2020
3	grazoprevirIBA 01/2022 - 07/2020
3	Reverse Transcriptase InhibitorsIBA 01/2020 - 01/2015
3	Interferon-alpha (Interferon Alfa)IBA 01/2017 - 12/2011
2	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 01/2022 - 01/2020
2	glecaprevir and pibrentasvirIBA 01/2022 - 01/2021
2	Cytochrome P-450 CYP3AIBA 12/2021 - 08/2013
2	letermovirIBA 11/2021 - 11/2020
2	Unithiol (DMPS)IBA 01/2021 - 01/2021
2	Hepatitis B e AntigensIBA 01/2020 - 12/2019
2	Ritonavir (Norvir)FDA Link 11/2019 - 11/2019
2	paritaprevirIBA 11/2019 - 05/2019
2	daclatasvirIBA 05/2019 - 03/2017
2	Prednisolone (Predate)FDA LinkGeneric 01/2016 - 01/2012
2	CholesterolIBA 01/2014 - 12/2011
2	peginterferon alfa-2b (Pegintron)FDA Link 11/2011 - 09/2011
1	Phosphotransferases (Kinase)IBA 03/2022
1	EnzymesIBA 01/2022
1	ruxolitinibIBA 12/2021
1	Cytochrome P-450 CYP2C9 InhibitorsIBA 12/2021
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 02/2021
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2021
1	Biological ProductsIBA 01/2021
1	sofosbuvir velpatasvir voxilaprevir drug combinationIBA 09/2020
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2020
1	ARC-520IBA 01/2020
1	entecavir FDA Link 01/2020
1	AntigensIBA 01/2020
1	NucleotidesIBA 01/2020
1	Opioid Analgesics (Opioids)IBA 01/2020
1	Aspartic Acid (Aspartate)FDA Link 12/2019
1	Peptide Hydrolases (Proteases)FDA Link 11/2019
1	ombitasvirIBA 05/2019
1	Cytochrome P-450 CYP2B1 (PROD)IBA 05/2019
1	sofosbuvir drug combination ledipasvirIBA 05/2019
1	dasabuvirIBA 05/2019
1	SimeprevirIBA 05/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	Lopinavir FDA Link 11/2018
1	Interferon-gamma (Interferon, gamma)IBA 01/2018
1	Bile Acids and Salts (Bile Acids)IBA 01/2018
1	Interferon LambdaIBA 10/2017
1	Toll-Like Receptors (Toll-Like Receptor)IBA 10/2017
1	DNA (Deoxyribonucleic Acid)IBA 10/2017
1	RHO(D) antibody (anti-D)IBA 10/2017

Therapy/Procedure

30	Therapeutics 03/2022 - 05/2004
3	Opiate Substitution Treatment 07/2022 - 01/2018
3	Duration of Therapy 01/2014 - 04/2006
2	Critical Care (Surgical Intensive Care) 01/2022 - 01/2020
2	Art Therapy 11/2019 - 01/2014
1	Renal Replacement Therapy (Therapies, Renal Replacement) 11/2021
1	Drug Therapy (Chemotherapy) 06/2017